Case Study

Airglove Medical Ltd

Key Highlights

  • Airglove Medical Ltd is a medical innovations company based in East Kilbride, Scotland specialising in developing and commercialising healthcare products aimed at improving patient care and clinical efficiency.
  • Their flagship product Airglove Arm is a thermal vasodilatory, CE certified device designed to facilitate cannulation of the peripheral veins in Difficult Intravenous Access Patients (DIVA). Since launch it has been adopted in over 140 NHS hospitals, and holds 22 patents across the UK, US, EU, Canada, and China.
  • Airglove Medical Ltd required academic expertise to help develop a second generation Airglove, delivering two distinct units: Airglove LEG for Peripheral Arterial Disease (PAD) treatment and Airglove ARM for Difficult Intravenous Access (DIVA) treatment to be used in both the UK and globally.
  • Interface linked them to Edinburgh Napier University as they had the necessary expertise and background IP in product, biomedical devices, electronics, electrical and power electronics designs.
  • Redesigning Airglove for the PAD market will be a disrupter, improving PAD treatment outcomes, increasing patient mobility, minimising leg amputations and delivering cost savings for the NHS.
  • Airglove technology has earned Airglove Medical Ltd several awards including the Seal of Excellence from the European Commission (2019), Runner-Up in the Medilink West Midlands Medical & Healthcare Business Awards for Partnership with the NHS (2018), shortlisted in the Medilink North Medical & Healthcare Business Awards for Partnership with the NHS (2025) and a finalist for Innovation of the Year at the Scottish Knowledge Exchange Awards (2024).
  • Airglove Medical Ltd has secured two rounds of co-investment funding totalling £500K from Scottish Enterprise and private investment. Airglove has created two new job posts and sustained two further posts.
Partners

Edinburgh Napier University

Sectors

Healthcare & Pharmaceuticals

Regions

Glasgow & Clyde Valley

Airglove innovative healthcare products disrupting the Peripheral Arterial Disease treatment market, improving patient care and leading to clinical efficiency.

Background

Airglove Medical Ltd is a Scottish medical innovations company based in East Kilbride, Scotland. The company was started in July 2016 formerly known as Green Cross Medico Ltd, with Chairman Giovanni (Gio) Benedetti, a serial entrepreneur, the driving force behind the company. They operate with a lean structure, focusing on innovation and collaboration with healthcare institutions.

The company specialises in developing and commercialising healthcare products aimed at improving patient care and clinical efficiency. Their flagship product, Airglove, is a patient warming system designed to facilitate intravenous access by gently warming the patient’s lower arm through an inflatable double walled glove which is thermally regulated, thus making veins more accessible for cannulation.

They developed Airglove Arm (first generation), a thermal vasodilatory, CE certified device designed to facilitate cannulation of the peripheral veins in difficult intravenous access patients (DIVA).  Airglove technology provides a safe, convenient and effective way of vasodilation treatment for DIVA patients, but Airglove Medical also recognised that their unique technology could be revolutionary for people who suffer from Peripheral Arterial Disease (PAD).

200M people globally suffer from Peripheral Arterial Disease (PAD) with 716,817 over 55’s in the UK with symptomatic PAD costing on average £23,502 per patient, per year (NICE). This is a common condition where a build-up of fatty deposits in the arteries restricts blood supply to the leg muscles and is treated by diet, reducing weight, reducing alcohol and exercise. However, in the UK every year there are 72,000 angioplasties, 18,000 lower limb bypasses and 3,500 amputations.

Current self-care therapy for PAD is walking therapy, which is difficult for people with moderate-to-severe PAD. Independent exploratory research indicates that gentle heat therapy delivers significant PAD benefits.

The Challenge

Airglove Medical required academic expertise to help develop a second generation Airglove, delivering two distinct units: Airglove LEG for Peripheral Arterial Disease (PAD) treatment and Airglove ARM for Difficult Intravenous Access (DIVA) treatment to be used in both the UK and globally.

The Solution

Expertise was required in the areas of product design, electronics, electrical engineering and biomedical devices, due to the company’s lack of knowledge in these areas.  Jackie Sanderson of Interface connected Airglove Medical with Edinburgh Napier University as they had the necessary expertise and background IP in product, biomedical devices, electronics, electrical and power electronics designs.

Working in partnership with Professor Chan Hwang See and the specialist academic team at Edinburgh Napier University the aim was to develop the first PAD prototype of Airglove LEG (with cradle resting unit).

Two new improved versions of the practical prototype of Airglove LEG resting unit (“Cradle”) were designed, built and tested at Edinburgh Napier’s in-house facility.

Several heat transfer measurements of the Airglove LEG unit were setup and carried out with good indication of thermal distribution on the human leg and by testing the power handling performance of the Airglove ARM unit, the results suggested that the existing 300W motor would suffice for the new Airglove LEG unit, leading to the development of a simulated electronic prototype for the Airglove unit.

Four students, three final year undergraduate students and one MSc student were involved in the product design including Computer Aided Design (CAD) drawing and prototyping, Printed Circuit Board (PCB) design and testing, electrical engineering as well as contributing to the medical device and signal processing of the product.

The students proposed new electronics features, i.e. remote control, battery power, new sensors, smart control unit and wireless connectivity of the device, for the future advanced model of the Airglove unit.

The project was funded through a Standard Innovation Voucher and Advanced Innovation Voucher.

The Benefits

  • Redesigning Airglove for the PAD market will be a disrupter, improving PAD treatment outcomes, increasing patient mobility, minimising leg amputations, and delivering cost savings for the NHS.
  • Development of Airglove technology for Peripheral Arterial Disease (PAD) opens up a significantly larger market for Airglove Medical Ltd both in the UK and internationally.
  • Airglove LEG supports the UK Government’s Healthy Ageing Grand Challenge and the NHS backlog reduction focussed on “New treatments and diagnostic and streamlined surgical methods believed to result in more patients being seen to quickly and safely”.
  • Airglove technology has earned Airglove Medical Ltd several awards including the Seal of Excellence from the European Commission (2019), Runner-Up in the Medilink West Midlands Medical & Healthcare Business Awards for Partnership with the NHS (2018), shortlisted in the Medilink North Medical & Healthcare Business Awards for Partnership with the NHS (2025) and a finalist for Innovation of the Year at the Scottish Knowledge Exchange Awards (2024).

Academic Benefits

  • Four students, three final year undergraduate students and one MSc student, involved in this project, have gained good industrial experience. They will be able to use the transferable skills and knowledge gained in product design, electronics circuit design, presentation, and communication skills from this project for their future career.
  • Applying the academic knowledge to new products designed for commercially established markets will deliver impact on accelerated timescales raising the profile and demonstrating the strengths of the university and its scope for further industrial collaboration.
  • The knowledge generated through this project will support future funding applications, inform several final-year and MSc student projects, and contribute to teaching materials—helping to equip the next generation of engineers with up-to-date, industry-relevant expertise.

The Next Steps

  • The Airglove LEG working prototype is to be used in the Human Factors Research and 1st Phase patient service evaluation trials in conjunction with Professor Philip Stather, Consultant Vascular and Endovascular Surgeon, Norfolk & Norwich University hospital.
  • An Innovate UK Fast Start Grant of £50K was secured to help further develop a new product, Airglove mobile. Airglove Medical Ltd are looking at other funding resources such as innovate UK, KTP etc. to continue to develop the advanced features of the Airglove unit.
  • Airglove Medical Ltd aim to apply for a Scottish Enterprise SMART Grant to continue the Airglove project and develop the Airglove unit for both the arm and the leg with AI technology.
  • Several BEng and MSc projects to be set up.